Search Result "Ongoing therapy against HCC"
Potential Nanoformulation Approaches for Delivery of HCC Therapeutic Agents
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010012
Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010003
Angiogenesis in Hepatocellular Carcinoma (HCC) and its Potential Applications in the Development of Anti-HCC Drugs
Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 3 Year: 2016
Author(s): Guang-Chun Sun,Dai-Wei Zhao,Xu Yang,Lichun Sun
Doi: 10.2174/9781681081557116030006
Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 1 Year: 2021 Page: 3107-3146
Author(s): Tao Wang,Qiting Zhang,Ning Wang,Ziqi Liu,Bin Zhang,Yufen Zhao
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5239-5249
Author(s): Samuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
Targeted Therapies in Hepatocellular Carcinoma
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 8 Year: 2014 Page: 966-974
Author(s): F. Bronte, G. Bronte, S. Cusenza, E. Fiorentino, C. Rolfo, G. Cicero, E. Bronte, V. Di Marco, A. Firenze, G. Angarano, T. Fontana, A. Russo
New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 2 Year: 2011 Page: 260-266
Author(s): Fabio Farinati, Nora Cazzagon, Anna Giacomin, Anna
The Development of Targeted Therapies for Hepatocellular Cancer
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 3 Year: 2007 Page: 3292-3300
Author(s): D. Chattopadhyay, D. M. Manas, H. L. Reeves
Advancements in Hepatocellular Carcinoma: Potential Preclinical Drugs and their Future
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 1 Year: 2023 Page: 2-14
Author(s): Sultan Nacak Baytas
Molecular Pathways and Related Target Therapies in Liver Carcinoma
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 3 Year: 2007 Page: 3279-3287
Author(s): S. Tommasi, R. Pinto, B. Pilato, A. Paradiso